company background image
1720 logo

Standard Chemical & Pharmaceutical TWSE:1720 Stock Report

Last Price

NT$61.90

Market Cap

NT$11.1b

7D

1.1%

1Y

-3.6%

Updated

06 Feb, 2025

Data

Company Financials

Standard Chemical & Pharmaceutical Co. Ltd.

TWSE:1720 Stock Report

Market Cap: NT$11.1b

1720 Stock Overview

Standard Chemical & Pharmaceutical Co. Ltd. More details

1720 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance2/6
Financial Health6/6
Dividends4/6

My Notes

Capture your thoughts, links and company narrative

Standard Chemical & Pharmaceutical Co. Ltd. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Standard Chemical & Pharmaceutical
Historical stock prices
Current Share PriceNT$61.90
52 Week HighNT$79.40
52 Week LowNT$60.00
Beta0.14
1 Month Change1.14%
3 Month Change-3.28%
1 Year Change-3.58%
3 Year Change43.29%
5 Year Change84.23%
Change since IPO185.16%

Recent News & Updates

Standard Chemical & Pharmaceutical (TWSE:1720) Is Increasing Its Dividend To NT$2.70

Jul 29
Standard Chemical & Pharmaceutical (TWSE:1720) Is Increasing Its Dividend To NT$2.70

Standard Chemical & Pharmaceutical (TWSE:1720) Will Pay A Larger Dividend Than Last Year At NT$2.70

Jul 14
Standard Chemical & Pharmaceutical (TWSE:1720) Will Pay A Larger Dividend Than Last Year At NT$2.70

Recent updates

Standard Chemical & Pharmaceutical (TWSE:1720) Is Increasing Its Dividend To NT$2.70

Jul 29
Standard Chemical & Pharmaceutical (TWSE:1720) Is Increasing Its Dividend To NT$2.70

Standard Chemical & Pharmaceutical (TWSE:1720) Will Pay A Larger Dividend Than Last Year At NT$2.70

Jul 14
Standard Chemical & Pharmaceutical (TWSE:1720) Will Pay A Larger Dividend Than Last Year At NT$2.70

If You Like EPS Growth Then Check Out Standard Chem & Pharm (TPE:1720) Before It's Too Late

Apr 13
If You Like EPS Growth Then Check Out Standard Chem & Pharm (TPE:1720) Before It's Too Late

A Look At The Fair Value Of Standard Chem & Pharm CO., LTD. (TPE:1720)

Mar 14
A Look At The Fair Value Of Standard Chem & Pharm CO., LTD. (TPE:1720)

Does Standard Chem & Pharm (TPE:1720) Have A Healthy Balance Sheet?

Mar 01
Does Standard Chem & Pharm (TPE:1720) Have A Healthy Balance Sheet?

Should Standard Chem & Pharm (TPE:1720) Be Disappointed With Their 11% Profit?

Feb 16
Should Standard Chem & Pharm (TPE:1720) Be Disappointed With Their 11% Profit?

Is Standard Chem & Pharm CO., LTD.'s (TPE:1720) 4.3% Dividend Worth Your Time?

Feb 03
Is Standard Chem & Pharm CO., LTD.'s (TPE:1720) 4.3% Dividend Worth Your Time?

Standard Chem & Pharm CO., LTD.'s (TPE:1720) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Jan 19
Standard Chem & Pharm CO., LTD.'s (TPE:1720) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Here's Why I Think Standard Chem & Pharm (TPE:1720) Might Deserve Your Attention Today

Jan 04
Here's Why I Think Standard Chem & Pharm (TPE:1720) Might Deserve Your Attention Today

Is Standard Chem & Pharm CO., LTD. (TPE:1720) Popular Amongst Insiders?

Dec 22
Is Standard Chem & Pharm CO., LTD. (TPE:1720) Popular Amongst Insiders?

A Look At The Fair Value Of Standard Chem & Pharm CO., LTD. (TPE:1720)

Dec 08
A Look At The Fair Value Of Standard Chem & Pharm CO., LTD. (TPE:1720)

Standard Chem & Pharm (TPE:1720) Seems To Use Debt Rather Sparingly

Nov 26
Standard Chem & Pharm (TPE:1720) Seems To Use Debt Rather Sparingly

Shareholder Returns

1720TW PharmaceuticalsTW Market
7D1.1%2.9%-1.4%
1Y-3.6%1.8%25.5%

Return vs Industry: 1720 underperformed the TW Pharmaceuticals industry which returned 1.8% over the past year.

Return vs Market: 1720 underperformed the TW Market which returned 25.5% over the past year.

Price Volatility

Is 1720's price volatile compared to industry and market?
1720 volatility
1720 Average Weekly Movement1.9%
Pharmaceuticals Industry Average Movement3.9%
Market Average Movement4.5%
10% most volatile stocks in TW Market8.0%
10% least volatile stocks in TW Market2.1%

Stable Share Price: 1720 has not had significant price volatility in the past 3 months compared to the TW market.

Volatility Over Time: 1720's weekly volatility (2%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1967n/aTzu-Ting Fanwww.standard.com.tw

Standard Chemical & Pharmaceutical Co. Ltd. engages in the manufacture and sale of pharmaceutical products, supplements, and APIs in Taiwan and internationally. The company offers various pharmaceutical products for metabolic, respiratory, musculoskeletal, digestive, circulatory system, topical dermatological, cardiovascular system, anti-infectives, urogenital system and sex hormones, and others.

Standard Chemical & Pharmaceutical Co. Ltd. Fundamentals Summary

How do Standard Chemical & Pharmaceutical's earnings and revenue compare to its market cap?
1720 fundamental statistics
Market capNT$11.06b
Earnings (TTM)NT$847.58m
Revenue (TTM)NT$6.71b

13.1x

P/E Ratio

1.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
1720 income statement (TTM)
RevenueNT$6.71b
Cost of RevenueNT$3.77b
Gross ProfitNT$2.94b
Other ExpensesNT$2.09b
EarningsNT$847.58m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)4.74
Gross Margin43.81%
Net Profit Margin12.63%
Debt/Equity Ratio6.0%

How did 1720 perform over the long term?

See historical performance and comparison

Dividends

4.4%

Current Dividend Yield

57%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/06 19:29
End of Day Share Price 2025/02/06 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Standard Chemical & Pharmaceutical Co. Ltd. is covered by 6 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Qing Rong LinE.Sun Securities Investment Consulting Co. Ltd.
Regina LeeIBTS Investment Consulting Co., Ltd.
Li-chun ChangJih Sun Securities Investment Consulting Co., Ltd.